Marshall S. Stanton - 21 Nov 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
SVP, Clinical & MD Affair
Signature
/s/ Marshall Stanton
Issuer symbol
AORT
Transactions as of
21 Nov 2025
Net transactions value
-$1,460,932
Form type
4
Filing time
24 Nov 2025, 17:23:45 UTC
Previous filing
24 Nov 2025
Next filing
28 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stanton Marshall S. SVP, Clinical & MD Affair 1655 ROBERTS BLVD., NW, KENNESAW /s/ Marshall Stanton 24 Nov 2025 0001849615

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $374,350 +20,301 +45% $18.44 65,054 21 Nov 2025 Direct
transaction AORT Common Stock Sale $655,189 -14,586 -22% $44.92 50,468 21 Nov 2025 Direct F1
transaction AORT Common Stock Sale $259,152 -5,715 -11% $45.35 44,753 21 Nov 2025 Direct F2
transaction AORT Common Stock Options Exercise $298,637 +27,075 +60% $11.03 71,828 21 Nov 2025 Direct
transaction AORT Common Stock Sale $840,042 -18,705 -26% $44.91 53,123 21 Nov 2025 Direct F3
transaction AORT Common Stock Sale $379,538 -8,370 -16% $45.34 44,753 21 Nov 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -20,301 -100% $0.000000 0 21 Nov 2025 Common Stock 20,301 $18.44 Direct F5
transaction AORT Stock Options (Right to buy) Options Exercise $0 -27,075 -100% $0.000000 0 21 Nov 2025 Common Stock 27,075 $11.03 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects weighted average price. Range of prices were between $44.26 to $45.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Reflects weighted average price. Range of prices were between $45.26 to $45.54. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects weighted average price. Range of prices were between $44.26 to $45.255. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects weighted average price. Range of prices were between $45.26 to $45.53. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.
F6 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.